Page last updated: 2024-11-05

thalidomide and Angioma

thalidomide has been researched along with Angioma in 7 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.

Research Excerpts

ExcerptRelevanceReference
"Hemangiomas are benign neoplasms of the vasculature frequently encountered in children."2.47Hemangiomas - current therapeutic strategies. ( Mabeta, P; Pepper, MS, 2011)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Khurana, A1
Savitha, B1
Adam, Z1
Pour, L1
Krejcí, M1
Pourová, E1
Synek, O1
Zahradová, L1
Navrátil, M1
Mechl, M1
Nebeský, T1
Neubauer, J1
Feit, J1
Vokurková, J1
Král, Z1
Bednarík, O1
Slampa, P1
Dolezalová, H1
Hájek, R1
Mayer, J1
Mabeta, P1
Pepper, MS1
Lindner, DJ1
Jarvi, K1
Roebuck, DJ1
Sebire, NJ1
Lindley, K1
Shah, N1
Salomon, J1
Curry, JI1
Roe, FJ1
Walters, MA1
Kida, M1
Lenz, W1

Reviews

3 reviews available for thalidomide and Angioma

ArticleYear
[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].
    Vnitrni lekarstvi, 2010, Volume: 56, Issue:8

    Topics: Adult; Aged; Angiogenesis Inhibitors; Angiomatosis; Female; Hemangioma; Humans; Interferon-alpha; Ma

2010
Hemangiomas - current therapeutic strategies.
    The International journal of developmental biology, 2011, Volume: 55, Issue:4-5

    Topics: Angiogenesis Inhibitors; Bleomycin; Child; Cyclophosphamide; Hemangioma; Humans; Interferons; Neovas

2011
Interferons as antiangiogenic agents.
    Current oncology reports, 2002, Volume: 4, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Syne

2002

Other Studies

4 other studies available for thalidomide and Angioma

ArticleYear
Refractory angiolymphoid hyperplasia with eosinophilia: Complete resolution with low dose thalidomide.
    Pediatric dermatology, 2022, Volume: 39, Issue:6

    Topics: Angiolymphoid Hyperplasia with Eosinophilia; Head; Hemangioma; Humans; Rare Diseases; Thalidomide

2022
Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog.
    Journal of pediatric gastroenterology and nutrition, 2008, Volume: 46, Issue:5

    Topics: Angiogenesis Inhibitors; Female; Hemangioma; Humans; Infant; Intestinal Neoplasms; Somatostatin; Tha

2008
Sensitivity of newborn mice to carcinogenic agents.
    Food and cosmetics toxicology, 1968, Volume: 6, Issue:5

    Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Benz(a)Anthracenes; Carcinogens; Carcinoma, Hepa

1968
[Thalidomide embryopathy in Japan].
    Archiv fur Kinderheilkunde, 1968, Volume: 177, Issue:3

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Ear; Ectromelia; Female; Fetal Diseases; Finge

1968